Syndax Pharmaceuticals Inc. | Balance Sheet
Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
14,314.00
12,142.00
86,543.00
105,481.00
130,080.00
81,012
Total Accounts Receivable
-
35.00
258.00
306.00
377.00
253
Other Current Assets
230.00
267.00
1,206.00
2,723.00
2,985.00
2,081
Total Current Assets
14,544.00
12,444.00
88,007.00
108,510.00
133,442.00
83,346
Net Property, Plant & Equipment
40.00
33.00
88.00
260.00
267.00
373
Total Investments and Advances
-
-
-
-
3,246.00
-
Other Assets
2,477.00
339.00
1,808.00
243.00
231.00
219
Total Assets
17,061.00
12,816.00
89,903.00
109,013.00
137,186.00
83,938
ST Debt & Current Portion LT Debt
-
6,449.00
-
-
-
Accounts Payable
1,077.00
354.00
1,452.00
2,375.00
2,232.00
Other Current Liabilities
1,653.00
3,543.00
3,395.00
7,991.00
13,566.00
Total Current Liabilities
2,730.00
10,346.00
4,847.00
10,366.00
15,798.00
Long-Term Debt
-
7,435.00
-
-
-
Other Liabilities
2,482.00
751.00
18,358.00
14,508.00
17,069.00
Total Liabilities
5,212.00
18,532.00
23,205.00
24,874.00
32,867.00
Common Equity (Total)
135,706.00
159,800.00
259,646.00
84,139.00
104,319.00
Total Shareholders' Equity
11,849.00
5,716.00
66,698.00
84,139.00
104,319.00
Total Equity
11,849.00
5,716.00
66,698.00
84,139.00
104,319.00
Liabilities & Shareholders' Equity
17,061.00
12,816.00
89,903.00
109,013.00
137,186.00
Preferred Stock (Carrying Value)
147,555.00
154,084.00
326,344.00
-
-
About Syndax Pharmaceuticals
View Profile
